Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases
, , , y
07 mar 2020
Acerca de este artículo
Categoría del artículo: research article
Publicado en línea: 07 mar 2020
Páginas: 86 - 95
DOI: https://doi.org/10.2478/raon-2020-0011
Palabras clave
© 2020 Katja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, Vita Dolzan, Alenka Franko, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Goricar, Katja
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Kovac, Viljem
Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Dodic-Fikfak, Metoda
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Clinical Institute of Occupational Medicine, University Medical Centre LjubljanaLjubljana, Slovenia
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Franko, Alenka
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Clinical Institute of Occupational Medicine, University Medical Centre LjubljanaLjubljana, Slovenia